Raycome RBP-1200
The technology used in the Raycome RBP-1200, to measure blood pressure, has passed in a clinical validation study, in a young population, according to a recognised standard protocol, as published in a peer-reviewed publication.
Accuracy Assessment | Recommendation | Basis | ||
---|---|---|---|---|
Medaval | Recommended for children only | Validation in children | ||
ESH (Europe) | Self-measurement for children | Published evidence | ||
Stride BP | Professional use for children (Preferred) | Published evidence | ||
MDR Criteria | Self-measurement for children | Published evidence |
Dong J, Dong H, Ye P, Yan Y, Xi B, Mi J. Validation of the Raycome RBP-1200 upper-arm pulse wave device in children aged 3-12 years according to the Association for the Advancement of Medical Instrumentation protocol. Blood Press Monit. 2017 Feb;22(1):40-3. doi: 10.1097/MBP.0000000000000217. PMID: 27749333.
81060-2:2013 - Pass Children (n=87)